Volume 2, Issue 5
The Ways of Optimizing Treatment the Patients with Liver Cirrhosis
Author: Iryna Gavrysh*
Department of Therapy and Family Medicine of Postdiploma Faculty, Ivano-Frankivsk National Medical University, 76000, Ivano-Frankivsk, Ukraine
Abstract: We examined 65 patients with liver cirrhosis combined with intestinal dysbiosis, studied the influence of the characteristics of its flow intestinal microbiota and included in the combined treatment of medications of Lactobacillus and Bifidobacterium – «Bifilakt Extra» (LB) and Methylsiliconic acid hydrogel – «Enterosgelum » (MAH). Inclusion to the complex treatment of the patients suffering from cirrhosis of medications LB and MAH led to a significantly better reduction of subjective and objective symptoms of liver cirrhosis, regimentation indicators of intestinal microbiota and symptoms of hepatic encephalopathy.
Download Full Article: Click Here
Support Us
If you are interested in supporting our work and would like to contribute, you are welcome to mail me at jpbr.anil@gmail.com or at info@thepharmajournal.com it will be a great help and will surely be appreciated.
